In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ContraVir Pharmaceuticals Inc. Trade Record

NASDAQ:CTRV ContraVir Pharmaceuticals Inc stock gains 8.54% Exit Jan 11, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart CTRV Jan 10, 2019, priceSeries
About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.

Trade Information
Trade Type
Entry Date
Jan 10, 2019
Entry Price
Sell Date
Jan 11, 2019
Sell Price
Net Gain
Hold Time
1 Trading Days